CDC intends to purchase 9M doses of smallpox vaccine from Emergent

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Emergent Biodefense Operations Lansing, a post to the Federal Business Opportunities website indicates. The Government intends to purchase 9 Million doses of Food And Drug Administration licensed ACAM2000 Smallpox Vaccine, at the time of award with the option to purchase 66 additional doses. This contract will have a 12 month base period and four 12 month option periods. “Emergent is the only FDA licensed provider of ACAM2000 Smallpox Vaccine and therefore is the only source capable to provide this requirement to the Government,” the post states.

https://bit.ly/2vO5CUF